Table 1.
Demographics of subjects (mean, standard deviation, range)
| Group | Gender (M/F) | Age (yrs) | Education (yrs) | Duration (yrs) | MDS-UPDRS III OFF | Hoehn & Yahr | BDI-II | MoCA | LEDD |
|---|---|---|---|---|---|---|---|---|---|
| PD without cognitive impairment (n=45) |
25/20 | 64.4 (8.0) 46 – 80 |
16.9 (2.3) 12 – 20 |
4.0 (3.4) 0 – 16 |
32.8 (10.8) 16 – 55 |
1.9 (0.4) 1 – 3 |
9.20 (7.64) 1 – 30 |
27.5 (2.1) 23 – 30 |
502.9 (339.1) 0 – 1580 |
| PD with cognitive impairment (n=40) |
28/12 | 70.0 (8.8) 42 – 86 |
16.6 (2.3) 12 – 20 |
6.3 (4.8) 0 – 22 |
38.2 (12.3) 11 – 62 |
2.4 (0.8) 1 – 4 |
11.89 (8.29) 0 – 40 |
21.5 (5.1) 8 – 30 |
479.3 (512.3) 0 – 1808 |
|
| |||||||||
| P value | 0.170 | 0.003 | 0.632 | 0.014 | 0.035 | <0.001 | 0.137 | <0.001 | 0.806 |
MDS-UPDRS, Movement Disorders Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale; BDI-II, Beck Depression Inventory-II; MoCA, Montreal Cognitive Assessment; LEDD, levodopa equivalence dose; Duration, duration since diagnosis; P, probability value